Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Iremia 400microgram sublingual tablets
0407020A0BYAPAZ
|
Iremia | Fentanyl | Central Nervous System | 4 |
|
Iremia 133microgram sublingual tablets
0407020A0BYAMBX
|
Iremia | Fentanyl | Central Nervous System | No data available |
|
Iremia 267microgram sublingual tablets
0407020A0BYANBZ
|
Iremia | Fentanyl | Central Nervous System | No data available |
|
Iremia 533microgram sublingual tablets
0407020A0BYAQBY
|
Iremia | Fentanyl | Central Nervous System | No data available |
|
Iremia 67microgram sublingual tablets
0407020A0BYARCH
|
Iremia | Fentanyl | Central Nervous System | No data available |
|
Iremia 800microgram sublingual tablets
0407020A0BYASBB
|
Iremia | Fentanyl | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.